BOARD
CEO of the Grünenthal Group (€ 1,4B Sales, 4’700 employees in 2019). Previously Company President of AstraZeneca Japan and Germany. Managed brands in immuno-oncology.
Former Head of Manufacturing at Mesoblast (NASDAQ: MESO). Ex- Professor at UTMD Anderson Cancer Center. Led the Cell Therapy Laboratory at UTMD and designed its facility.
SVP Global Clinical Development at Merck KGaA with a strong track record of drug approval (Rebif, Mavenclad). Previously Head of Scientific Affairs and Investor Relations at Serono (listing NYSE)
Non-executive director. Formerly Ambassador to The People’s Republic of China, to Mongolia and the DPRK (2014-2019). Previously Ambassador to France and Monaco (2011-2014).
MANAGEMENT TEAM
CEO
Serial entrepreneur and former. CEO of multiple companies with more than 30 years experience.
SCIENTIFIC & BUSINESS ADVISORS
This website contains information about products that may not be available in all countries, available under different trademarks or for different indications. Nothing contained herein should be considered a solicitation, promotion or advertisement for any product including those under development and described on this site. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider
© All rights reserved 2021 – MedXCell SA